Emerging Paradigms in Inflammatory Disease Management: Exploring Bioactive Compounds and the Gut Microbiota

Abstract

The human gut microbiota is a complex ecosystem of mutualistic microorganisms that play a critical role in maintaining human health through their individual interactions and with the host. The normal gastrointestinal microbiota plays a specific physiological function in host immunomodulation, nutrient metabolism, vitamin synthesis, xenobiotic and drug metabolism, maintenance of structural and functional integrity of the gut mucosal barrier, and protection against various pathogens. Inflammation is the innate immune response of living tissues to injury and damage caused by infections, physical and chemical trauma, immunological factors, and genetic derangements. Most diseases are associated with an underlying inflammatory process, with inflammation mediated through the contribution of active immune cells. Current strategies to control inflammatory pathways include pharmaceutical drugs, lifestyle, and dietary changes. However, this remains insufficient. Bioactive compounds (BCs) are nutritional constituents found in small quantities in food and plant extracts that provide numerous health benefits beyond their nutritional value. BCs are known for their antioxidant, antimicrobial, anticarcinogenic, anti-metabolic syndrome, and anti-inflammatory properties. Bioactive compounds have been shown to reduce the destructive effect of inflammation on tissues by inhibiting or modulating the effects of inflammatory mediators, offering hope for patients suffering from chronic inflammatory disorders like atherosclerosis, arthritis, inflammatory bowel diseases, and neurodegenerative diseases. The aim of the present review is to summarise the role of natural bioactive compounds in modulating inflammation and protecting human health, for their safety to preserve gut microbiota and improve their physiology and behaviour.

Critical review on anti‐inflammation effects of saponins and their molecular mechanisms

“…A healthy gut microbiota can enhance the anti-inflammatory potential of saponins, while an imbalanced microbiome may limit their effectiveness. Therefore, a diet rich in saponincontaining foods, along with a focus on gut health, can have a positive impact on inflammation and overall health (Benameur et al, 2023;L. Wang et al, 2022).…”

Functional and Therapeutic Potential of Cynara scolymus in Health Benefits

“…As discussed in various studies, bioactive compounds play a critical role in modulating inflammation, managing, and preventing many inflammatory diseases, including the inflammatory bowel diseases (IBDs) targeting gut microbiota [ 38 , 47 , 48 ]. As it was already mentioned, artichoke is a widely consumed vegetable known for its potential health benefits.…”

From the Gut to the Brain: Is Microbiota a New Paradigm in Parkinson’s Disease Treatment?

“…Despite the substantial growth in this area in recent years, it is still impossible to have direct correlations between the microorganisms in our gut microbiota and their role in the onset and progression of specific pathologies, such as PD [55,87]. Consequently, there is a paramount need to allocate resources towards comprehending intestinal microorganisms' diversity and their bioactive metabolites' functionality in the context of diverse diseases, including PD [88,89]. This strategic investment is essential for the eventual utilization of the intestinal microbiome in diagnosing and treating PD.…”